ClinicalTrials.gg
CompletedNCT05532228Updated Sep 8, 2022

Evaluation of the Functional Impact of Adenotonsilectomy

An observational study in Apnea, Obstructive, Tonsillitis and Tonsillar Hypertrophy, sponsored by Instituto de Ciências Biomédicas Abel Salazar. Completed at 1 site in Portugal. Open to participants aged 4 Years to 14 Years. Per ClinicalTrials.gov, last updated 2022-09-08.

Sponsored by Instituto de Ciências Biomédicas Abel Salazar · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
78
Ages
4 Years to 14 Years
Sex
All
01

Study summary

Spirometric assessment of respiratory function before and after adenotonsillectomy surgery

Read the detailed description

Spirometric assessment of respiratory function before and after adenotonsillectomy surgery Study site at CHUPorto: Department of Otorhinolaryngology at CHUPorto, Portugal.

Study design: Institutional, observational, cohort, prospective. Classification of studies according to the law of clinical investigation (Dec. Law No. 21/2014): Clinical study without intervention. Main objective of the study: To collect a database referring to pediatric patients enrolled for surgery in an outpatient setting, in order to compare vital, spirometric and clinical parameters at two different times: pre and post surgical intervention.

Secondary objectives of the study: Based on validated indices, to assess the impact of surgical intervention on the child's respiratory and cardiovascular system. Participants: Patients undergoing surgery in the field of Pediatric Otorhinolaryngology at CHUPorto, a tertiary referral Hospital in Portugal.

02

Conditions studied

  • Apnea, Obstructive
  • Tonsillitis
  • Tonsillar Hypertrophy
  • Respiratory Function Impaired
  • Infections
  • ENT Disorder

Keywords

  • adenotonsillectomy
  • children
  • spirometry
  • obstructive sleep apnea
  • adenotonsillar hypertrophy
  • respiratory function
03

In context

Sleep Apnea, Obstructive

2,240 studies on the registry are indexed under Sleep Apnea, Obstructive; 475 are open to participants now.

This study's enrollment of 78 is below the median of 105 across 666 observational studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

Instituto de Ciências Biomédicas Abel Salazar is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing surgery within the scope of Pediatric Otorhinolaryngology at CHUPorto.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 4-14 years;
  • Patients with surgical indication for any combination of:

    • tonsillectomy
    • adenoidectomy
    • turbinoplasty
    • myringotomy;
  • naive children (not submitted to previous ENT surgery);
  • signature of by the parent entity.

Exclusion criteria

Exclusion Criteria:

  • Age under 4 years and over 14 years;
  • surgery: myringotomy+TT placement exclusively;
  • associated co-morbidities:

    • asthma/other obstructive lung diseases
    • congenital facial or thoracic dysmorphism
    • neurological disease with cognitive impairment
    • cardiopulmonary disease
  • patients without surgical indication
  • other causes of nasal obstruction (severe septum deviation or polyps).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
78 participants (actual)
Patient registry
No

Groups and cohorts

  • Obstructive sleep apnea

    children with adenotonsillar hypertrophy and reports of nocturnal arousals/gasp/respiratory abnormalities

    Procedure: Adenotonsillectomy

  • No obstructive sleep apnea

    children without adenotonsillar hypertrophy and no reports of nocturnal arousals/gasp/respiratory abnormalities

    Procedure: Adenotonsillectomy

  • Recurrent infections

    Children with recurrent upper respiratory infections

    Procedure: Adenotonsillectomy

  • no recurrent infections

    Children without recurrent upper respiratory infections

    Procedure: Adenotonsillectomy

Interventions

  • ProcedureAdenotonsillectomy

    adenotonsillectomy by cold dissection

06

What researchers measure

Primary outcomes

  1. Forced expiratory volume in the first second (FEV 1)

    Measured in two moments by the same operator: pre-operatively, in the day of intervention and post-operatively, 3 months after surgery.

    Time frame: 3 months after surgery

  2. Forced vital capacity (FVC)

    Measured in two moments by the same operator: pre-operatively, in the day of intervention and post-operatively, 3 months after surgery.

    Time frame: 3 months after surgery

  3. Peak expiratory flow (PEF)

    Measured in two moments by the same operator: pre-operatively, in the day of intervention and post-operatively, 3 months after surgery.

    Time frame: 3 months after surgery

  4. forced expiratory flow rate at 25% (F25)

    Measured in two moments by the same operator: pre-operatively, in the day of intervention and post-operatively, 3 months after surgery.

    Time frame: 3 months after surgery

  5. forced expiratory flow rate at 75% (F75)

    Measured in two moments by the same operator: pre-operatively, in the day of intervention and post-operatively, 3 months after surgery.

    Time frame: 3 months after surgery

  6. forced expiratory flow between 25 and 75% of the pulmonary volume (FEF25-75%).

    Measured in two moments by the same operator: pre-operatively, in the day of intervention and post-operatively, 3 months after surgery.

    Time frame: 3 months after surgery

Secondary outcomes

  1. Weight

    Measured in two moments by the same operator: pre-operatively, in the day of intervention and post-operatively, 3 months after surgery.

    Time frame: 3 months after surgery

  2. Diastolic arterial pressure

    Measured in two moments by the same operator: pre-operatively, in the day of intervention and post-operatively, 3 months after surgery.

    Time frame: 3 months after surgery

  3. Systolic arterial pressure

    Measured in two moments by the same operator: pre-operatively, in the day of intervention and post-operatively, 3 months after surgery.

    Time frame: 3 months after surgery

  4. Heart rate

    Measured in two moments by the same operator: pre-operatively, in the day of intervention and post-operatively, 3 months after surgery.

    Time frame: 3 months after surgery

  5. rest oxygen saturation

    Measured in two moments by the same operator: pre-operatively, in the day of intervention and post-operatively, 3 months after surgery. (through instant photoplethysmography in the index finger with the patient in a calm environment

    Time frame: 3 months after surgery

07

Study locations

1 site
  • Centro Hospitalar Univrsitário do Porto
    Porto, 4099-001, Portugal
08

References and documents

Individual participant data

Plan to share: No — The investigators do not plan to share individual participant data

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05532228
Lead sponsor
Instituto de Ciências Biomédicas Abel Salazar
Responsible party
Sponsor
First posted
Sep 8, 2022
Start date
Aug 20, 2020
Primary completion
Dec 1, 2021
Completion
Feb 1, 2022
Last update
Sep 8, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion